Reliq Health Announces Call-In Details for Quarterly Reporting Call to Take Place on May 31, 2018
Reliq Health Technologies Inc. (RHT.V) (RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, will host an investor update conference call on May 31, 2018 to review the Company’s recent progress and answer questions from shareholders. The Company would also like to inform shareholders that it will be releasing its quarterly financial statements for Q3 FY2018 (January 1, 2018 – March 31, 2018) on May 30, 2018.
Conference Call Information:
| When: | May 31, 2018, 8:00am – 9:00am PST / 11:00am – noon EST | ||
| ID: | 9284748 | ||
| Dial In: | Canada and U.S. – (844) 461-9931 | ||
| International – (636) 812-6630 | |||
The Company would like to advise participants to join the conference call at least 10 minutes early in order to register. Investors are encouraged to submit questions in advance to info@reliqhealth.com as these questions will be addressed first, following which the moderator will open up the call to questions from investors who have registered and joined the queue. To join the queue participants will be asked to key in *1 at any point in the call. Once the questions submitted in advance via email have been addressed, the moderator will open the line to callers in the queue one at a time in order of priority. A recording of the conference call will be available afterwards until June 7, 2018, and will be accessible by calling either of the following numbers: (855) 859-2056 or (404) 537-3406.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Investor Relations at Reliq Health at IR@reliqhealth.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
